alpha-En Corp 8-K, filed Apr 2, 2020
alpha-En Corp (ALPE)
About this 8-K
alpha-En Corp filed this 8-K on April 2, 2020.
Items reported
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 2, 2020
ALPHA-EN CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 001-12885 | 95-4622429 | ||
| (State
or Other Jurisdiction of Incorporation) |
(Commission
File Number) |
(IRS
Employer Identification No.) |
28 Wells Avenue, 2nd Floor, Yonkers, New York
(Address of Principal Executive Offices)
(914) 418-2000
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| Common Stock, par value $0.01 per share | ALPE | OTC Markets |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240. 12b-2).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
| Item 7.01 | Regulation FD. |
On April 2, 2020 the Company issued a letter to its stockholders. The letter is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 7.01.
The information set forth in this report, including Exhibit 99.1 is furnished pursuant to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
| Item 9.01 | Financial Statements and Exhibits. |
| 99.1 | Letter to the Stockholders of alpha-En Corporation dated April 2, 2020 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ALPHA-EN CORPORATION | ||
| (Registrant) | ||
| Date: April 2, 2020 | By: | /s/ Sam Pitroda |
| Name: | Sam Pitroda | |
| Title: | Chief Executive Officer | |
Exhibit 99.1
| Dear Shareholders, | April 2, 2020 |
At this time of the year you are accustomed to getting a company update from Jerry Feldman but as you are aware his role has changed to Chairman Emeritus and he handed the Executive Chairman/CEO functions to me. So this is my first time writing the Chairman’s letter.
I am reaching out to you to brief you on the status of our company Alpha-en in these difficult times resulting from the global Coronavirus pandemic. It is unfortunate that we all have been affected by this crisis one way or the other in a way we had never imagined before.
In response to the coronavirus crisis, our first priority at Alpha-en was to make sure that we follow federal and state government guidelines to secure our employees, facilities, laboratory, supplies, samples, documentation and other assets including our suppliers & customers. At the same time, we had to make sure that our basic lab operates to assure continuity and quality. I am pleased to report to you that we have been able to accomplish all of these tasks in time to everyone’s satisfaction.
Before the coronavirus emergency shutdown we were working on NYSERDA grant related activities, preparing samples for potential customers, experimenting with different electrolytes to improve performance and preparing plans for Li recovery/recycling and Li extraction. We were also focused on getting additional investments to manage and expand our operation and business development. Once we are allowed to get back to work, we will pick up from where we have left. For now I have tasked our CFO and his team to carefully analyze the recently passed CARES Act to see if we can benefit from relevant portions of that package. This Act may provide significant resources to help us navigate the next few challenging months.
In the meantime, we remain optimistic about our technology and associated potential of the Li metal anode, Li extraction, & Li recovery/recycling market.
Thank you for your ongoing support and help in this long journey to become a major global player in the Li extraction & deposition process for the next generation energy market world over.
Wish you remain safe & healthy.
Sam Pitroda
